Want to see GOSS full AI Analyst Report?
Gossamer Bio (GOSS) Income Statement
Gossamer Bio Income Statement
Last quarter (Q2 2026), Gossamer Bio's total revenue was $9.24M, a decrease of 19.59% from the same quarter last year. In Q2, Gossamer Bio's net income was $16.90M. See Gossamer Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 48.47M | $ 114.70M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 47.47M | $ 114.70M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 210.72M | $ 174.62M | $ 183.76M | $ 218.59M | $ 216.12M | |
| Depreciation and Amortization | $ 1.00M | $ 4.15M | $ 4.38M | $ 4.43M | $ 5.17M |
| $ -158.47M | $ -39.97M | $ -161.92M | $ -211.07M | $ -209.40M | |
| $ -163.25M | $ -59.92M | $ -183.76M | $ -218.59M | $ -216.12M | |
| $ -7.21M | $ 4.28M | $ 3.94M | $ -10.79M | $ -17.88M | |
| $ -170.46M | $ -55.63M | $ -179.82M | $ -229.38M | $ -234.00M | |
| $ -170.37M | $ -56.53M | $ -179.82M | $ -229.38M | $ -234.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ -59.64 | $ -19.99 | $ -94.26 | $ -216.97 | $ -250.13 |
| Diluted EPS | $ -59.64 | $ -19.99 | $ -94.26 | $ -216.97 | $ -250.13 |
| Weighted Average Shares Outstanding | 2.86M | 2.83M | 1.91M | 1.06M | 935.54K |
| Weighted Average Shares Outstanding (Diluted) | 2.86M | 2.83M | 1.91M | 1.06M | 935.54K |
Currency in USD